Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: LACOSAMIDE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application (ANDA) for lacosamide as a generic product by Alembic Pharmaceuticals Inc., enabling its marketing as an antiseizure medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)